David Spaner

Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim et al. · Journal of Clinical Oncology · 2014 · 1.6K citations · Full text

Medicine, Hematology, Oncology +17

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman et al. · Blood · 2011 · 1.4K citations

Life Sciences, Hematology, Immunology +17

Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study

Asher Chanan‐Khan, Kena C. Miller, Laurie Musial et al. · Journal of Clinical Oncology · 2006 · 409 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype

Raphaëlle Romieu‐Mourez, Moïra François, Marie‐Noëlle Boivin et al. · The Journal of Immunology · 2009 · 310 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Hypersensitivity to natural latex

David Spaner, Jerry Dolovich, Susan M. Tarlo et al. · Journal of Allergy and Clinical Immunology · 1989 · 152 citations · Full text

Life Sciences, Immunology, Allergy +10